Trials / Active Not Recruiting
Active Not RecruitingNCT05855239
Quantification of Hepatic Steatosis With Different Ultrasound Frequency
Quantification of Hepatic Steatosis in Patients With Fatty Liver Disease Using Attenuation Imaging With Different Ultrasound Frequency
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Jong Keon Jang · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is: (1) to compare the feasibility (technical successes rate and reliability) in measuring attenuation coefficient between two different frequencies (3MHz, 4MHz) of ultrasound beam; (2) to evaluate and compare the diagnostic performance of attenuation coefficient for steatosis using two different frequencies (3MHz, 4MHz) of ultrasound beam by comparison with the pathologic results acquired by liver biopsy or surgery.
Detailed description
Investigators measure the distance between the skin and liver capsule on B-mod images. Investigators place a region of interest (ROI) avoiding reverberation artifacts and acquire attenuation coefficient for five times. For participants who require a liver biopsy, investigators try to target the same area in the liver, where ROI was placed. Investigators evaluate hepatic steatosis, lobular inflammation, and fibrosis of tissue of the liver using a scoring system suggested by Nonalcoholic Steatohepatitis Clinical Research Network.
Conditions
Timeline
- Start date
- 2023-06-08
- Primary completion
- 2024-06-30
- Completion
- 2024-12-31
- First posted
- 2023-05-11
- Last updated
- 2024-08-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05855239. Inclusion in this directory is not an endorsement.